Antimicrobial Resistance to 3GC and Carbapenems in Enterobacterales: The role of the Rapid Phenotypic Diagnostic Test

30 Apr 2021

Antimicrobial Resistance to 3GC and Carbapenems in Enterobacterales:

The role of the Rapid Phenotypic  Diagnostic Test

 

5 prestigiosi relatori internazionali affrontano la cruciale tematica dell’emergenza globale causata dalla Resistenza Antimicrobica alle Cefalosporine di 3 generazione e ai Carbapenemi negli Enterobacterales e il l’importanza del ruolo dei Test Diagnostici Fenotipici RAPIDI

 

 

RELATORI 

Moderator: Giuliana Lo Cascio - Microbiology and Virology Complex Operational Unit, Hospital of Piacenza. Italy -

The antimicrobial resistance to 3GC and Carbapenems: the global threat

 

Belén Rivaya - Microbiology Lab from Hospital de Asturias - Spain -

Antimicrobial Resistances to 3GC and Carbapenems: the HUCA's Microbiology lab experience

 

Diego Fernando Josa M. - Fundación Clínica Shaio Bogotà and Infectious Diseases Dep. at Universidad de La Sabana. Colombia -

Impact of the new protocol for the rapid phenotypic detection of ESBL and CRE in blood cultures and rapid  screening of CRE in adult and pediatric patients

 

Veronica Seija Sarconi - Universidad de la República and Depto de Laboratorio Clínico. Hospital de Clínicas Montevideo. Uruguay -

Management of Cabapenem resistances in Uruguay: routine experience using Alifax CRE screening kit

 

Vittorio Sambri  - Bologna University and Microbiology Unit of the Great Romagna Hub Laboratory, Cesena. Italy -

Evaluation study of ESBL/AmpC Screening KIT for positive blood culture in 3 hours

 

 

 

 

scopri i contenuti guardando la registrazione su ALIFAX WEBINAR CHANNEL 

 

 Per maggiori informazioni visita la pagina dedicata al prodotto MDRO